Ces radiol. 2018, 72(2):100-105 | DOI: 10.55095/CesRadiol2018/017
Downstaging of hepatocellular carcinoma before liver transplantationOriginal article
- Základna radiodiagnostiky a intervenční radiologie IKEM, Praha
Aim: Presentation of our experience with downstaging of hepatocellular carcinoma (HCC) in patients originally exceeding current liver transplant criteria.
Method: Between 2013 and 2017 thirteen patients with HCC exceeding Milan and UCSF liver transplant criteria were treated by transarterial chemoembolization (TACE) as downstaging method. Superselective embolization with drug-eluting beads was performed in all patients, doxorubicin loaded DC beads 100-300 μm were applied to tumor feeding artery.
Results: Downstaging was successful in all patients. Tumor response to embolization was evaluated by modified RECIST criteria on CT, all patients met Milan criteria and joined the waiting list for transplantation. Ten patients were successfully transplanted.
Conclusion: Drug-eluting bead TACE is acceptable method to achieve successfull downstaging of HCC to Milan criteria in selected patients.
Keywords: downstaging, transarterial chemoembolization, DC Bead, hepatocellular carcinoma, liver transplantation
Accepted: April 16, 2018; Published: June 1, 2018 Show citation
References
- Trunečka P, Adamec M. Transplantace jater. Praha: Karolinum 2009; 39-194.
- Sharr W, Chan S, Lo Ch. Current status of downstaging of hepatocellular carcinoma before liver transplantation. Transplantation 2014; 97: 10-17.
Go to original source...
Go to PubMed...
- Yao F, Mehta N, Flemming J, et al. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within milan criteria. Hepatology 2015; 61: 1968-1977.
Go to original source...
Go to PubMed...
- Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patient with cirhosis. N Engl J Med 1996; 334: 693-699.
Go to original source...
Go to PubMed...
- Mazzarerro V, Llovet J M, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43.
Go to original source...
Go to PubMed...
- Pompili M, francica G, Ponziani FR, Iezzi R, Avolio AW. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation. Word J Gastroenterol 2013; 19: 7515-7530.
Go to original source...
Go to PubMed...
- Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolisation on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688-701.
Go to original source...
Go to PubMed...
- Parikh ND, Waljee AK, Singal AG. Downstaging hepatocellular carcinoma: a systematic rewiew and pooled analysis. Liver transplantation 2015; 21: 1142-1152.
Go to original source...
Go to PubMed...
- Green TJ, Rochon PJ, Chang S, et al. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization. J Vasc Interv Radiol 2013; 24: 1613-1622.
Go to original source...
Go to PubMed...
- Murali AR, Romero-Marrero C, Miller Ch, et al. Predictors of successful downstaging of hepatocellular carcinoma outside Milan criteria. Transplantation 2016; 11: 2391-2397.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.